Fenix Therapeutics addresses the critical challenges in cancer treatment by focusing on the Notch pathway, a key factor in therapy resistance in many human cancers.

Saturn offers a personalized solution for Pelvic Organ Prolapse by providing a pessary with a perfect fit and optimal support for each patient's complex, unique anatomy.

With Fybrix, we offer a synthetic, customizable and animal-free 3D cell culture material that uniquely mimics the native cell environment, in contrast to other synthetic materials that have been introduced in the market.

Next-generation gene promoters for more stable and higher recombinant protein expression.

Pionering whole genome sequencing based genotoxicity testing

GlycoCheck measures and analyzes microvascular health, and objectively reports a MicroVascular Health Score (MVHS)

A robust patient monitoring device which is highly reliable and easy to use to prevent children in low and middle income countries unnecessary dying from severe bacterial infections.

HELIA Biomonitoring’s mission is to enable continuous monitoring of therapeutic drug concentrations, organ function markers, and treatment response markers for personalized patient care.

the HUB provides access to a unique and robust platform that links patient-specific genetic and phenotypic information to preclinical and clinical drug-responsiveness.

Hy2Care develops a so called “injectable plaster” to repair the cartilage surface.